Andrew Rapkin is an experienced investor and entrepreneur currently serving as Lead Investor and Board Observer at CND Life Sciences since January 2021. Additionally, Andrew holds roles as an Investor/Consultant at Revert Technologies, and as an Investor at CodeTogether Inc., with further investment responsibilities across multiple companies including Fido, Upflex, Entelligent, Smart Access, Eventy, and CLICS. As President of Remedios LLC since 2014, Andrew oversees a portfolio of 22 companies focusing on seed and early-stage ventures in diverse sectors such as manufacturing, eLearning, biotech, and SaaS. Andrew's academic background includes an MBA in Finance and Entrepreneurial Management from The Wharton School and a B.S. in Biology with a focus on Environmental Policy from Tufts University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices